Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
70
PharmaCompass offers a list of Sodium Zirconium Cyclosilicate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Sodium Zirconium Cyclosilicate manufacturer or Sodium Zirconium Cyclosilicate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sodium Zirconium Cyclosilicate manufacturer or Sodium Zirconium Cyclosilicate supplier.
A ZS-9 compound manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of ZS-9 compound, including repackagers and relabelers. The FDA regulates ZS-9 compound manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. ZS-9 compound API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of ZS-9 compound manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A ZS-9 compound supplier is an individual or a company that provides ZS-9 compound active pharmaceutical ingredient (API) or ZS-9 compound finished formulations upon request. The ZS-9 compound suppliers may include ZS-9 compound API manufacturers, exporters, distributors and traders.
click here to find a list of ZS-9 compound suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A ZS-9 compound DMF (Drug Master File) is a document detailing the whole manufacturing process of ZS-9 compound active pharmaceutical ingredient (API) in detail. Different forms of ZS-9 compound DMFs exist exist since differing nations have different regulations, such as ZS-9 compound USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A ZS-9 compound DMF submitted to regulatory agencies in the US is known as a USDMF. ZS-9 compound USDMF includes data on ZS-9 compound's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The ZS-9 compound USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of ZS-9 compound suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a ZS-9 compound Drug Master File in Korea (ZS-9 compound KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of ZS-9 compound. The MFDS reviews the ZS-9 compound KDMF as part of the drug registration process and uses the information provided in the ZS-9 compound KDMF to evaluate the safety and efficacy of the drug.
After submitting a ZS-9 compound KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their ZS-9 compound API can apply through the Korea Drug Master File (KDMF).
click here to find a list of ZS-9 compound suppliers with KDMF on PharmaCompass.
A ZS-9 compound written confirmation (ZS-9 compound WC) is an official document issued by a regulatory agency to a ZS-9 compound manufacturer, verifying that the manufacturing facility of a ZS-9 compound active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting ZS-9 compound APIs or ZS-9 compound finished pharmaceutical products to another nation, regulatory agencies frequently require a ZS-9 compound WC (written confirmation) as part of the regulatory process.
click here to find a list of ZS-9 compound suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing ZS-9 compound as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for ZS-9 compound API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture ZS-9 compound as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain ZS-9 compound and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a ZS-9 compound NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of ZS-9 compound suppliers with NDC on PharmaCompass.
ZS-9 compound Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of ZS-9 compound GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right ZS-9 compound GMP manufacturer or ZS-9 compound GMP API supplier for your needs.
A ZS-9 compound CoA (Certificate of Analysis) is a formal document that attests to ZS-9 compound's compliance with ZS-9 compound specifications and serves as a tool for batch-level quality control.
ZS-9 compound CoA mostly includes findings from lab analyses of a specific batch. For each ZS-9 compound CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
ZS-9 compound may be tested according to a variety of international standards, such as European Pharmacopoeia (ZS-9 compound EP), ZS-9 compound JP (Japanese Pharmacopeia) and the US Pharmacopoeia (ZS-9 compound USP).
